The Life Sciences Virtual Investor Forum, co-hosted by B2i Digital, Inc. and Zacks Small-Cap Research, will take place on June 24 and 25, 2026, offering investors two days of live presentations and direct engagement with management teams from more than 20 public companies across biotechnology, diagnostics, medical devices, and digital health. The forum, part of B2i Digital's Featured Conference series, aims to streamline access for investors seeking to evaluate life sciences companies at various stages of development.
B2i Digital serves as the Official Marketing Partner for the event, leveraging its proprietary network of over 1.7 million retail and institutional market participants to amplify the presentations and facilitate one-on-one meetings. The company's distribution engine has supported more than 115 investor conferences, underscoring its role in connecting companies with qualified investors. Zacks Small-Cap Research, a preferred provider in the OTC Markets Group's Research Marketplace, brings its team of life sciences analysts to co-host the forum, providing independent research and analysis to attendees.
The lineup includes clinical-stage biotech firms developing therapies for rare diseases and oncology, molecular diagnostics companies, medical device innovators, veterinary medicine specialists, nutrition science ventures, and AI-powered digital health platforms. Each presenting company will have 30 minutes for a live presentation followed by a real-time Q&A session. Investors can also request one-on-one meetings with management teams through the Axle Access platform. Replays of the presentations will be available on the B2i Digital and OTC Markets YouTube channels.
David Shapiro, Chief Executive Officer of B2i Digital, emphasized the value of pairing direct access to management teams with independent research. "Life sciences investors want efficient, direct access to management teams developing the therapies and technologies that matter, and pairing that access with independent research from Zacks makes the forum more valuable on both sides," Shapiro said. The forum is designed to help investors reach their own conclusions by engaging with companies across a broad spectrum of life sciences sectors.
Presenting companies on Day One (June 24) include Protalix BioTherapeutics, MetaVia Inc., CytoSorbents Corporation, PetVivo Holdings Inc., Jaguar Health, Inc., Reviva Pharmaceuticals Holdings, Inc., and 4DMedical Ltd. Day Two (June 25) features Prostatype Genomics AB, Abingdon Health plc, Innovotech, Inc., Lakewood-Amedex Biotherapeutics Inc., Nasus Pharma Ltd., Kelyniam Global, Inc., IMUNON, Inc., Promino Nutritional Sciences Inc., Envoy Medical Inc., Coiled Therapeutics plc, Aspire Biopharma Holdings Inc., Rocket Doctor AI Inc., Phio Pharmaceuticals Corp., aTyr Pharma, Inc., and NuFarm Ltd. The schedule is subject to change.
Registration and company profiles are available through the Virtual Investor Conferences website. The event is part of a series that features public companies from exchanges worldwide, including NYSE, Nasdaq, TSX, TSXV, CSE, ASX, LSE, and OTC Markets. Virtual Investor Conferences is a property of OTC Markets Group Inc.
B2i Digital, founded in 2021 by David Shapiro, a former Maxim Group investment banker and Chief Marketing Officer, partners with investor conferences, public companies, and capital markets advisors through its Featured Conference, Featured Company, and Featured Expert programs. The firm positions itself as "The Capital Markets Matchmaker," connecting investors and companies through digital marketing, conferences, and direct meetings. Zacks Small-Cap Research develops independent company-sponsored research for distribution across investor and media channels, focusing on building awareness among long-term investors.
The forum underscores the growing demand for targeted investor access in the life sciences sector, where understanding complex science and regulatory pathways is critical. By combining live presentations, Q&A, and one-on-one meetings, the event provides a comprehensive platform for due diligence and relationship building.
